Sexually Transmitted Disease Therapeutic Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Sexually Transmitted Disease Therapeutic Market to 2027 - Global Analysis and Forecasts By Disease Type(Gonorrhea, Chlamydia, Syphilis, Herpes, Hepatitis, HIV and Other Indications); Therapy Type(Anti-bacterial Drugs, Anti-Viral Drugs and Anti-Fungal Drugs); Route of Administration(Oral, Injectable and Topical); Distribution Channel(Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.)

Report Code: TIPRE00003726 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Sexually Transmitted Disease or STD is a venereal clinical syndrome of infection, attained and transmitted through sexual activity via body fluids such as semen, vaginal fluid or blood. Causative agent of STD are bacteria, parasites, yeast and viruses.

MARKET DYNAMICS
The Sexually Transmitted Disease Therapeutics market is anticipated to grow in the forecast period owing to driving factors such as increasing sexually transmitted disease and rising governmental initiatives to spread awareness through organization of campaigns and free diagnostic camps. Nevertheless, the growth of this market could face restraints owing to factors such as low rate of screening for diseases and late diagnosis of disease such as HIV.

MARKET SCOPE
The "Global Sexually Transmitted Disease Therapeutics Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Sexually Transmitted Disease Therapeutics market with detailed market segmentation by Disease Type, Therapy Type, Route of Administration, Distribution Channels and Geography. The Sexually Transmitted Disease Therapeutics is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Sexually Transmitted Disease Therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The Sexually Transmitted Disease Therapeutics is segmented by Disease Type, Therapy Type, Route of Administration and Distribution Channels. On the basis of Disease Type the market is segmented as Gonorrhea, Chlamydia, Syphilis, Herpes, Hepatitis, HIV and Other Indications. On the basis of Therapy type the market is segmented as Anti-bacterial Drugs, Anti-Viral Drugs and Anti-Fungal Drugs. On the basis of Route of Administration the market is segmented as Oral, Injectable and Topical. On the basis of Distribution Channels the market is segmented as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Sexually Transmitted Disease Therapeutics based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Sexually Transmitted Disease Therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Sexually Transmitted Disease Therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Sexually Transmitted Disease Therapeutics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Sexually Transmitted Disease Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Sexually Transmitted Disease Therapeutics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Sexually Transmitted Disease Therapeutics in the global market. Below mentioned is the list of few companies engaged in the Sexually Transmitted Disease Therapeutics market.

The report also includes the profiles of key Sexually Transmitted Disease Therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Merck & Co. Inc
  • Pfizer INC,
  • GlaxoSmithKline Plc
  • Vertex Pharmaceuticals
  • Roche
  • Gilead Sciences Inc
  • AbbVie Inc.
  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Biomerieux
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sexually Transmitted Disease Therapeutics Market - By Disease Type
1.3.2 Sexually Transmitted Disease Therapeutics Market - By Therapy Type
1.3.3 Sexually Transmitted Disease Therapeutics Market - By Route of Administration
1.3.4 Sexually Transmitted Disease Therapeutics Market - By Distribution Channels
1.3.5 Sexually Transmitted Disease Therapeutics Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. GONORRHEA
7.3.1. Overview
7.3.2. Gonorrhea Market Forecast and Analysis
7.4. CHLAMYDIA
7.4.1. Overview
7.4.2. Chlamydia Market Forecast and Analysis
7.5. SYPHILIS
7.5.1. Overview
7.5.2. Syphilis Market Forecast and Analysis
7.6. HERPES
7.6.1. Overview
7.6.2. Herpes Market Forecast and Analysis
7.7. HEPATITIS
7.7.1. Overview
7.7.2. Hepatitis Market Forecast and Analysis
7.8. HIV
7.8.1. Overview
7.8.2. HIV Market Forecast and Analysis
7.9. OTHER INDICATIONS
7.9.1. Overview
7.9.2. Other Indications Market Forecast and Analysis
8. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
8.1. OVERVIEW
8.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANTI-BACTERIAL DRUGS
8.3.1. Overview
8.3.2. Anti-bacterial Drugs Market Forecast and Analysis
8.4. ANTI-VIRAL DRUGS
8.4.1. Overview
8.4.2. Anti-Viral Drugs Market Forecast and Analysis
8.5. ANTI-FUNGAL DRUGS
8.5.1. Overview
8.5.2. Anti-Fungal Drugs Market Forecast and Analysis
9. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INJECTABLE
9.4.1. Overview
9.4.2. Injectable Market Forecast and Analysis
9.5. TOPICAL
9.5.1. Overview
9.5.2. Topical Market Forecast and Analysis
10. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNELS
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES.
10.5.1. Overview
10.5.2. Online Pharmacies. Market Forecast and Analysis
11. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Sexually Transmitted Disease Therapeutics Market Overview
11.1.2 North America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis
11.1.3 North America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Disease Type
11.1.4 North America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Therapy Type
11.1.5 North America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Route of Administration
11.1.6 North America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Distribution Channels
11.1.7 North America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Sexually Transmitted Disease Therapeutics Market
11.1.7.1.1 United States Sexually Transmitted Disease Therapeutics Market by Disease Type
11.1.7.1.2 United States Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.1.7.1.3 United States Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.1.7.1.4 United States Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.1.7.2 Canada Sexually Transmitted Disease Therapeutics Market
11.1.7.2.1 Canada Sexually Transmitted Disease Therapeutics Market by Disease Type
11.1.7.2.2 Canada Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.1.7.2.3 Canada Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.1.7.2.4 Canada Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.1.7.3 Mexico Sexually Transmitted Disease Therapeutics Market
11.1.7.3.1 Mexico Sexually Transmitted Disease Therapeutics Market by Disease Type
11.1.7.3.2 Mexico Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.1.7.3.3 Mexico Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.1.7.3.4 Mexico Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.1.7.4 US Sexually Transmitted Disease Therapeutics Market
11.1.7.4.1 US Sexually Transmitted Disease Therapeutics Market by Disease Type
11.1.7.4.2 US Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.1.7.4.3 US Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.1.7.4.4 US Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.2. EUROPE
11.2.1 Europe Sexually Transmitted Disease Therapeutics Market Overview
11.2.2 Europe Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis
11.2.3 Europe Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Disease Type
11.2.4 Europe Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Therapy Type
11.2.5 Europe Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Route of Administration
11.2.6 Europe Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Distribution Channels
11.2.7 Europe Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Sexually Transmitted Disease Therapeutics Market
11.2.7.1.1 Germany Sexually Transmitted Disease Therapeutics Market by Disease Type
11.2.7.1.2 Germany Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.2.7.1.3 Germany Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.2.7.1.4 Germany Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.2.7.2 France Sexually Transmitted Disease Therapeutics Market
11.2.7.2.1 France Sexually Transmitted Disease Therapeutics Market by Disease Type
11.2.7.2.2 France Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.2.7.2.3 France Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.2.7.2.4 France Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.2.7.3 Italy Sexually Transmitted Disease Therapeutics Market
11.2.7.3.1 Italy Sexually Transmitted Disease Therapeutics Market by Disease Type
11.2.7.3.2 Italy Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.2.7.3.3 Italy Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.2.7.3.4 Italy Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.2.7.4 Spain Sexually Transmitted Disease Therapeutics Market
11.2.7.4.1 Spain Sexually Transmitted Disease Therapeutics Market by Disease Type
11.2.7.4.2 Spain Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.2.7.4.3 Spain Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.2.7.4.4 Spain Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.2.7.5 United Kingdom Sexually Transmitted Disease Therapeutics Market
11.2.7.5.1 United Kingdom Sexually Transmitted Disease Therapeutics Market by Disease Type
11.2.7.5.2 United Kingdom Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.2.7.5.3 United Kingdom Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.2.7.5.4 United Kingdom Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Overview
11.3.2 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Disease Type
11.3.4 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Therapy Type
11.3.5 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Route of Administration
11.3.6 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Distribution Channels
11.3.7 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Sexually Transmitted Disease Therapeutics Market
11.3.7.1.1 Australia Sexually Transmitted Disease Therapeutics Market by Disease Type
11.3.7.1.2 Australia Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.3.7.1.3 Australia Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.3.7.1.4 Australia Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.3.7.2 China Sexually Transmitted Disease Therapeutics Market
11.3.7.2.1 China Sexually Transmitted Disease Therapeutics Market by Disease Type
11.3.7.2.2 China Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.3.7.2.3 China Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.3.7.2.4 China Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.3.7.3 India Sexually Transmitted Disease Therapeutics Market
11.3.7.3.1 India Sexually Transmitted Disease Therapeutics Market by Disease Type
11.3.7.3.2 India Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.3.7.3.3 India Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.3.7.3.4 India Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.3.7.4 Japan Sexually Transmitted Disease Therapeutics Market
11.3.7.4.1 Japan Sexually Transmitted Disease Therapeutics Market by Disease Type
11.3.7.4.2 Japan Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.3.7.4.3 Japan Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.3.7.4.4 Japan Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Overview
11.4.2 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Disease Type
11.4.4 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Therapy Type
11.4.5 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Route of Administration
11.4.6 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Distribution Channels
11.4.7 Middle East and Africa Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Sexually Transmitted Disease Therapeutics Market
11.4.7.1.1 South Africa Sexually Transmitted Disease Therapeutics Market by Disease Type
11.4.7.1.2 South Africa Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.4.7.1.3 South Africa Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.4.7.1.4 South Africa Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.4.7.2 Saudi Arabia Sexually Transmitted Disease Therapeutics Market
11.4.7.2.1 Saudi Arabia Sexually Transmitted Disease Therapeutics Market by Disease Type
11.4.7.2.2 Saudi Arabia Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.4.7.2.3 Saudi Arabia Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.4.7.2.4 Saudi Arabia Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.4.7.3 U.A.E Sexually Transmitted Disease Therapeutics Market
11.4.7.3.1 U.A.E Sexually Transmitted Disease Therapeutics Market by Disease Type
11.4.7.3.2 U.A.E Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.4.7.3.3 U.A.E Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.4.7.3.4 U.A.E Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Sexually Transmitted Disease Therapeutics Market Overview
11.5.2 South and Central America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis
11.5.3 South and Central America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Disease Type
11.5.4 South and Central America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Therapy Type
11.5.5 South and Central America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Route of Administration
11.5.6 South and Central America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Distribution Channels
11.5.7 South and Central America Sexually Transmitted Disease Therapeutics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Sexually Transmitted Disease Therapeutics Market
11.5.7.1.1 Brazil Sexually Transmitted Disease Therapeutics Market by Disease Type
11.5.7.1.2 Brazil Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.5.7.1.3 Brazil Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.5.7.1.4 Brazil Sexually Transmitted Disease Therapeutics Market by Distribution Channels
11.5.7.2 Argentina Sexually Transmitted Disease Therapeutics Market
11.5.7.2.1 Argentina Sexually Transmitted Disease Therapeutics Market by Disease Type
11.5.7.2.2 Argentina Sexually Transmitted Disease Therapeutics Market by Therapy Type
11.5.7.2.3 Argentina Sexually Transmitted Disease Therapeutics Market by Route of Administration
11.5.7.2.4 Argentina Sexually Transmitted Disease Therapeutics Market by Distribution Channels
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET, KEY COMPANY PROFILES
13.1. MERCK & CO. INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. PFIZER INC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLAXOSMITHKLINE PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. VERTEX PHARMACEUTICALS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ROCHE
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GILEAD SCIENCES INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ABBVIE INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. JOHNSON & JOHNSON
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BRISTOL-MYERS SQUIBB
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIOMERIEUX
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Merck & Co. Inc
2. Pfizer INC,
3. GlaxoSmithKline Plc
4. Vertex Pharmaceuticals
5. Roche
6. Gilead Sciences Inc
7. AbbVie Inc.
8. Johnson & Johnson
9. Bristol-Myers Squibb
10. Biomerieux
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book